NCT00430027: Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma |
|
|
| Terminated | N/A | 8 | US | Capecitabine, Xeloda, Oxaliplatin, Eloxatin, Cetuximab, Erbitux | University of Colorado, Denver, Bristol-Myers Squibb, Sanofi | Esophageal Adenocarcinoma | 08/08 | 08/08 | | |
mEGA, NCT02358863: Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach |
|
|
| Terminated | N/A | 13 | US | Modified FOLFOX6, Oxaliplatin, Eloxatin, Leucovorin, 5-FU, 5-Flourouracil, Docetaxel/Capecitabine, Taxotere, Xeloda, Cisplatin/Irinotecan, Platinum, CPT-11, Camptosar, Cisplatin/Docetaxel, IRI/EPI, Irinotecan, Epirubicin, EPI/Docetaxel, Irinotecan/Docetaxel, Docetaxel | Georgetown University | Esophageal Cancer, Gastric Cancer | 11/16 | 11/16 | | |
